Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J Piddock

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
The Journal of Antimicrobial Chemotherapy|August 1, 1991
Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strainsL J Piddock, M C Hall, R N Walters
The Veterinary Record|May 12, 1990
Nalidixic acid-resistant salmonellaeC Wray, I McLaren, R Wise, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1987
The effect of imipenem on strains of Enterobacteriaceae expressing Richmond & Sykes class I beta-lactamasesJ Ashby, B Kirkpatrick, L J Piddock, et al.
Lancet (London, England)|July 14, 1990
Quinolone resistance in Salmonella spp: veterinary pointersL J Piddock, C Wray, I McClaren, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1997
Non-gyrA-mediated ciprofloxacin resistance in laboratory mutants of Streptococcus pneumoniaeL J Piddock, Y F Jin, M J Everett
The Journal of Antimicrobial Chemotherapy|August 1, 1998
Role of mutation in the gyrA and parC genes of nalidixic-acid-resistant salmonella serotypes isolated from animals in the United KingdomL J Piddock, V Ricci, I McLaren, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1993
High-level quinolone resistance amongst clinical isolates of Escherichia coli and Klebsiella pneumoniae from SpainT Alarcón, J Pita, M López-Brea, et al.
Antimicrobial Agents and Chemotherapy|October 31, 1998
Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tractL J Piddock, M Johnson, V Ricci, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1985
The antimicrobial activity of cefpirome, a new cephalosporinR Wise, J M Andrews, C Cross, et al.
Antimicrobial Agents and Chemotherapy|September 26, 1997
Adaptive mutations produce resistance to ciprofloxacinC Riesenfeld, M Everett, L J Piddock, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
The Journal of Antimicrobial Chemotherapy|August 1, 1991
Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strainsL J Piddock, M C Hall, R N Walters
The Veterinary Record|May 12, 1990
Nalidixic acid-resistant salmonellaeC Wray, I McLaren, R Wise, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1987
The effect of imipenem on strains of Enterobacteriaceae expressing Richmond & Sykes class I beta-lactamasesJ Ashby, B Kirkpatrick, L J Piddock, et al.
Lancet (London, England)|July 14, 1990
Quinolone resistance in Salmonella spp: veterinary pointersL J Piddock, C Wray, I McClaren, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1997
Non-gyrA-mediated ciprofloxacin resistance in laboratory mutants of Streptococcus pneumoniaeL J Piddock, Y F Jin, M J Everett
The Journal of Antimicrobial Chemotherapy|August 1, 1998
Role of mutation in the gyrA and parC genes of nalidixic-acid-resistant salmonella serotypes isolated from animals in the United KingdomL J Piddock, V Ricci, I McLaren, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1993
High-level quinolone resistance amongst clinical isolates of Escherichia coli and Klebsiella pneumoniae from SpainT Alarcón, J Pita, M López-Brea, et al.
Antimicrobial Agents and Chemotherapy|October 31, 1998
Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tractL J Piddock, M Johnson, V Ricci, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1985
The antimicrobial activity of cefpirome, a new cephalosporinR Wise, J M Andrews, C Cross, et al.
Antimicrobial Agents and Chemotherapy|September 26, 1997
Adaptive mutations produce resistance to ciprofloxacinC Riesenfeld, M Everett, L J Piddock, et al.
Pageof 10